Home
About
Overview
Our Team
Contact Us
Science
Our Science
MNTF Discovery
GM6 Development
GM6 and the Blood-Brain-Barrier
Neuroprotection
Drug Properties
Pipeline
CNS Indications
GM6 in CNS
ALS
Parkinson's Disease
Alzheimer's Disease
Stroke
Multiple Sclerosis
Spinal Cord Injury
Newsroom
What's New
Media
Contact
Home
About
Overview
Our Team
Contact Us
Science
Our Science
MNTF Discovery
GM6 Development
GM6 and the Blood-Brain-Barrier
Neuroprotection
Drug Properties
Pipeline
CNS Indications
GM6 in CNS
ALS
Parkinson's Disease
Alzheimer's Disease
Stroke
Multiple Sclerosis
Spinal Cord Injury
Newsroom
What's New
Media
Contact
Animal Models Data
Science (OLD)
Innovation + Patents
Pipeline
Clinical Trials
Trial Data
Mechanisms of Actions
Alzheimer's Disease Animal Model Data
ASENT 2021 Annual Meeting | Dr. Mark S. Kindy, Ph.D., FAHA
GM6 attenuates inflammation in Alzheimer’s disease pathology via modulation of fibrinogen by reducing Ab and tau
Click the video to view
Download Slide Presentation
GM6 Can Block Tau Hyperphosphorylation Induced by AGEs and Aβ
Download poster
GM6 Lowers Tau Hyperphosphorylation, Lowers Inflammation, and Improves Memory in h-Tau Mice
Download Poster
GM6 Attenuates Alzheimer’s Disease Pathology in APP Mice
Download Poster